(Q43604509)

English

Air Force/Texas Coronary Atherosclerosis Prevention Study (AFCAPS/TEXCAPS): additional perspectives on tolerability of long-term treatment with lovastatin

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

25 November 2017

Air Force/Texas Coronary Atherosclerosis Prevention Study (AFCAPS/TEXCAPS): additional perspectives on tolerability of long-term treatment with lovastatin (English)

1 reference

Europe PubMed Central

25 November 2017

atherosclerosis

1 reference

based on heuristic

inferred from title

author name string

Downs JR

1

1 reference

Europe PubMed Central

25 November 2017

Clearfield M

2

1 reference

Europe PubMed Central

25 November 2017

Tyroler HA

3

1 reference

Europe PubMed Central

25 November 2017

Whitney EJ

4

1 reference

Europe PubMed Central

25 November 2017

Kruyer W

5

1 reference

Europe PubMed Central

25 November 2017

Langendorfer A

6

1 reference

Europe PubMed Central

25 November 2017

Zagrebelsky V

7

1 reference

Europe PubMed Central

25 November 2017

Weis S

8

1 reference

Europe PubMed Central

25 November 2017

Shapiro DR

9

1 reference

Europe PubMed Central

25 November 2017

Beere PA

10

1 reference

Europe PubMed Central

25 November 2017

Gotto AM

11

1 reference

Europe PubMed Central

25 November 2017

language of work or name

0 references

publication date

1 May 2001

1 reference

Europe PubMed Central

25 November 2017

American Journal of Cardiology

1 reference

Europe PubMed Central

25 November 2017

87

1 reference

Europe PubMed Central

25 November 2017

1074-1079

1 reference

Europe PubMed Central

25 November 2017

9

1 reference

Europe PubMed Central

25 November 2017

Primary prevention of acute coronary events with lovastatin in men and women with average cholesterol levels: results of AFCAPS/TexCAPS. Air Force/Texas Coronary Atherosclerosis Prevention Study

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2801%2901464-3

7 January 2021

Design & rationale of the Air Force/Texas Coronary Atherosclerosis Prevention Study (AFCAPS/TexCAPS)

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2801%2901464-3

7 January 2021

The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels. Cholesterol and Recurrent Events Trial investigators

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2801%2901464-3

7 January 2021

Safety and tolerability of cholesterol lowering with simvastatin during 5 years in the Scandinavian Simvastatin Survival Study

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2801%2901464-3

7 January 2021

Prevention of cardiovascular events and death with pravastatin in patients with coronary heart disease and a broad range of initial cholesterol levels

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2801%2901464-3

7 January 2021

Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. West of Scotland Coronary Prevention Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2801%2901464-3

7 January 2021

An overview of the clinical safety profile of atorvastatin (lipitor), a new HMG-CoA reductase inhibitor

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2801%2901464-3

7 January 2021

Itraconazole drastically increases plasma concentrations of lovastatin and lovastatin acid

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2801%2901464-3

7 January 2021

Lovastatin and coadministered antihypertensive/cardiovascular agents

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2801%2901464-3

7 January 2021

Antiatherothrombotic properties of statins: implications for cardiovascular event reduction.

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2801%2901464-3

7 January 2021

Pathways of coagulation/fibrinolysis activation in malignancy.

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2801%2901464-3

7 January 2021

Sunlight and cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2801%2901464-3

7 January 2021

Risk for subsequent cancer after diagnosis of basal-cell carcinoma. A population-based, epidemiologic study

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2801%2901464-3

7 January 2021

Increased cancer mortality following a history of nonmelanoma skin cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2801%2901464-3

7 January 2021

Cholesterol reduction yields clinical benefit: impact of statin trials

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2801%2901464-3

7 January 2021

Identifiers

10.1016/S0002-9149(01)01464-3

1 reference

Europe PubMed Central

25 November 2017

1 reference

Europe PubMed Central

25 November 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q43604509&oldid=2101849220"